Brief: Celldex Therapeutics Q3 EPS USD -0.81
02/11/2023 21:13
Nov 2 (Reuters) - Celldex Therapeutics Q3 net income USD -38.26 million. * Q3 EPS USD -0.81 * Q3 revenue USD 1.517 million vs. IBES estimate USD 575.3 thousand * Q3 operating income USD -41.239 million
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials